| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| venBio Global Strategic Fund III, L.P. | 10%+ Owner | $92,846,916 | 19 Sep 2023 | ||
| Redmile Group, LLC | 10%+ Owner | $33,438,708 | 19 Sep 2023 | ||
| L.P. Wellington Biomedical Innovation Master Investors (Cayman) II | 10%+ Owner | $28,041,228 | 19 Sep 2023 | ||
| Maha Katabi | Director | $0 | 26 Feb 2024 | ||
| Susan Moran | Chief Medical Officer | $0 | 26 Feb 2024 | ||
| VIKING GLOBAL INVESTORS LP | 10%+ Owner | $0 | 26 Feb 2024 | ||
| KENNETH SONG | PRESIDENT AND CHIEF EXECUTIVE, Director | $0 | 26 Feb 2024 | ||
| Arvind Kush | Chief Financial Officer | $0 | 26 Feb 2024 | ||
| Richard A. Heyman | Director | $0 | 26 Feb 2024 | ||
| Aaron Royston | Director | 14 Sep 2023 | |||
| Yi Larson | Director | 26 Feb 2024 | |||
| Versant Ventures VII GP-GP, LLC | 10%+ Owner | 14 Sep 2023 | |||
| Timothy Van Hauwermeiren | Director | 26 Feb 2024 | |||
| Angie You | Director | 26 Feb 2024 | |||
| MARY TAGLIAFERRI | Director | 26 Feb 2024 | |||
| Christy J. Oliger | Director | 26 Feb 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|